Skip to main content
Clinical Trials/NCT04496843
NCT04496843Active, not recruitingNot Applicable

Validation of the Diagnostic Performance of the Sleep Apnea Syndrome by the Withings HWA09 Device

Withings2 sites in 2 countries220 target enrollmentStarted: January 16, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Withings
Enrollment
220
Locations
2
Primary Endpoint
Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 5/h in PSG

Study Overview

Brief Summary

Sleep Apnea Syndrome (SAS) is a common pathology affecting between 4 and 8% of the general population. It aggravates morbidity and cardio-metabolic mortality and is responsible for accidents related to vigilance disorders. It is estimated that 80%% of SAS cases are not diagnosed and therefore not treated. It is however impracticable to propose a diagnostic test of polygraphy (PG) or polysomnography (PSG) to every patient because of the cost and insufficient availability of these exams. It would therefore be useful to carry out a screening test before directing the patient to a complete test.

Several simplified polygraph systems with 2 or 3 channels have been proposed (nasal cannula, oximetry, heart rate) but they generally record only one night and remain intrusive enough to perturb the sleep.

The Withings HWA09 is a wrist-worn watch, which allows screening of SAS from four signals: movement, heart rate, breathing rate and blood oxygen saturation (SpO2). The objective of the present study is to validate the diagnostic performance of the Withings HWA09 for the detection of SAS compared to PSG.

Detailed Description

Subjects are patients having a prescription for a one-night polysomnographic consultation in order to diagnose potential sleep disorders. The investigator will collect the consent before including any patient in this study. The study last one night per patient, during which saturation signal recordings and the sleep apnea detection will be made by the HWA09 watch, in comparison to the polysomnography.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults, men and women, between 18 and 70 y/o
  • Patient addressed for a polysomnography because of a suspicion of sleep respiratory disorders
  • Subject having expressed his/her consent to take part in the study

Exclusion Criteria

  • Recording under continuous positive pressure
  • Subject having refuse to give his/her consent
  • Vulnerable subjects according to regulation in force :
  • Pregnant, parturient or breastfeeding women
  • Subjects having a known allergy to one of the components of the sensor (silicon, stainless steel, sapphire glass)
  • Subjects deprived of liberty by a court, medical or administrative order
  • Subjects legally protected or unable to express their non-opposition to take part in the study
  • Subjects unable to express their consent due to linguistic or mental incapacities

Arms & Interventions

Patients referred for an overnight in-lab PSG

Simultaneous assessment of SAS with Withings HWA09 Device and overnight PSG

Intervention: HWA09 Measurement (Diagnostic Test)

Outcomes

Primary Outcomes

Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 5/h in PSG

Time Frame: 1 year

Sensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at apnea-hypopnea index (AHI) threshold value of 5/h in PSG.

Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 15/h in PSG

Time Frame: 1 year

Sensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at AHI threshold value of 15/h in PSG.

Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 30/h in PSG

Time Frame: 1 year

Sensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at AHI threshold value of 30/h in PSG.

Secondary Outcomes

  • Sensitivity and Specificity of the desaturation detected by Withings HWA09(1 year)
  • Accuracy of Withings HWA09 to estimate total sleep time (TST) given by PSG(1 year)
  • Impact of the proportion of apnea events on the performance of Withings HWA09(1 year)
  • Impact of the proportion of hypopnea events on the performance of Withings HWA09(1 year)
  • Influence of the position of the sleeper (supine vs prone/lateral decubitus position) on the error of the AHI predicted by Withings HWA09 compared with PSG(1 year)
  • Reliability of Withings HWA09(1 year)

Investigators

Sponsor
Withings
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Validation of the Diagnostic Performance... | Clinical Trial